Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement

DSpace/Manakin Repository

Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement

Citable link to this page

 

 
Title: Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement
Author: Marchini, Julio F.; Miyakawa, Ayumi Aurea; Tarasoutchi, Flavio; Krieger, José Eduardo; Lemos, Pedro; Croce, Kevin

Note: Order does not necessarily reflect citation order of authors.

Citation: Marchini, Julio F., Ayumi Aurea Miyakawa, Flavio Tarasoutchi, José Eduardo Krieger, Pedro Lemos, and Kevin Croce. 2016. “Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement.” Journal of Negative Results in Biomedicine 15 (1): 7. doi:10.1186/s12952-016-0051-2. http://dx.doi.org/10.1186/s12952-016-0051-2.
Full Text & Related Files:
Abstract: Background: Patients with severe aortic stenosis have increased levels of prothrombotic and proinflammatory microparticles (MP), and MPs actively regulate pathological processes that lead to atherothrombotic cardiovascular events. Shear stress is a validated stimulus of MP production, and abnormal shear stress in aortic stenosis increases MP release in ex-vivo studies. We hypothesized that in patients with severe aortic stenosis, percutaneous replacement of the aortic valve (TAVR) would reduce abnormal shear stress and would decrease levels of circulating MPs. Findings: The experimental protocol utilized flow cytometry (FC) and nanoparticle tracking analysis (NTA) to quantify circulating plasma MP levels in aortic stenosis patients at baseline and 5 days after TAVR. The baseline and 5 day MP counts measured by FC were 6.10⋅105 ± 1.21⋅105 MP/μL and 5.74⋅105 ± 9.54⋅104 MP/μL, respectively (p = 0.91). The baseline and 5 day MP counts measured by NTA were 9.29⋅1013 ± 1.66⋅1013 MP/μL and 3.95⋅1014 ± 3.11⋅1014 MP/μL, respectively (p = 0.91). When MPs were stratified by cell source, there was no difference in pre/post TAVR endothelial, platelet, or leukocyte MP levels. Conclusion: Levels of circulating MPs do not change acutely following TAVR therapy for aortic stenosis. Trial registered at clinicaltrials.gov NCT02193035 on July 11, 2014. Electronic supplementary material The online version of this article (doi:10.1186/s12952-016-0051-2) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12952-016-0051-2
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827212/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:26860121
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters